Post# 1606134992

23-Nov-2020 6:36 pm


Oxford/AstraZeneca/ChaDox1 vaccine

Phase 3 trial results out today.

- 2 dosing regimens evaluated

  • Efficacy regimen 1 (1/2 dose, followed by full dose 1 month apart): 90%
  • Efficacy regimen 2 (2 full doses 1 mo. apart): 62%
    -Average efficacy 70%
    -Fridge storage (2-8 degree C)
    -Well tolerated

    ////

    Now these numbers can swing a lot like how full+full swings a lot from half+full doze. Performed worse than the other two. But the storage requirement is promising.

    23-Nov-2020 6:36 pm

  • Published
    23-Nov-2020